Nothing reaches a patientuntil someone provesit is safe.
SynCRO runs the viral clearance, potency, and biosafety testing that turns your process into evidence a regulator can accept. Formerly Texcell North America, backed by a global virus safety group that has run viral clearance studies since 1990.
Four services. One safety story.
Most sponsors come to us for viral clearance. They stay because the potency, production, and analytical work sits under the same roof, run by the same people, on the same timeline.
Three reasons sponsors stay
Clearance studies, designed for the filing they end up in
A clearance study is not one study.
It is a panel decision, a set of worst case conditions, and a stack of preliminary work that determines whether the real study is worth running.
Every therapy in our labs is somebody’s last good option. Between that therapy and that person is a set of questions about safety that has to be answered with evidence, not intent.
Answering those questions is the whole job. We do it carefully, we do it on the schedule we committed to, and we tell you what the data says even when it is not what you hoped for.
Where the work happens
BSL-2 and BSL-3 containment, a virus library built over three decades, and standard HPLC capability on site. Our North America operation is expanding into a new purpose-built facility.
Request a facility overview →Tell us what you are trying to clear.
Send us your process, your stage, and your target filing date. We will tell you what studies you need, what you can skip, and what it will take to get there.
Start a conversation